{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/096/SRR30042996/SRR30042996_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/097/SRR30042997/SRR30042997_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/098/SRR30042998/SRR30042998_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/098/SRR30042998/SRR30042998_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/099/SRR30042999/SRR30042999_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/096/SRR30042996/SRR30042996_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/097/SRR30042997/SRR30042997_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/099/SRR30042999/SRR30042999_1.fastq.gz"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["FuDan university"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1142001"],"scientific_name":["Homo sapiens"],"tag":["xref:PubMed:39542248"],"long_description":["Enhancing host anti-tumor immunity is paramount for advancing cancer immunotherapy. Here, we identify CWF19-like cell cycle control factor 1 (CWF19L1) as a promising immunotherapeutic target that functions as a splicing factor to enhance T cell-mediated cytotoxicity. CWF19L1 interacts prominently with key splicing factors and regulators, including U5 small nuclear ribonucleoprotein (snRNP) and the pre-mRNA processing factor 19 (PRPF19) complex. Deficiency of CWF19L1 leads to aberrant alternative splicing of immune-related genes and repression of cytotoxic molecule expression. Furthermore, CWF19L1 plays a pivotal role in promoting T cell-mediated anti-tumor immunity by upregulating effector cytokine expression. Our findings unveil previously undocumented functions of CWF19L1 in alternative splicing and its crucial involvement in anti-tumor immunity. These insights underscore the potential of targeting CWF19L1 for the development of novel cancer immunotherapies. Overall design: To examine the possible role of CWF19L1 in mRNA splicing, we performed RNA sequencing on control Jurkat cells (shCtrl) and CWF19L1 knockdown Jurkat cells (shCWF19L1)."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"CWF19L1 promotes T-cell cytotoxicity through the regulation of alternative splicing","description":"CWF19L1 promotes T-cell cytotoxicity through the regulation of alternative splicing","dates":{"last_updated":"2025-09-24","first_public":"2024-08-06"},"accession":"PRJNA1142001","cross_references":{"GEO":["GSE273485"],"taxon":["9606"],"PubMed":["39542248"]}}